Inventiva S.A. (EPA: IVA)
France
· Delayed Price · Currency is EUR
2.400
-0.180 (-6.98%)
Nov 21, 2024, 12:45 PM CET
Inventiva Employees
As of December 31, 2023, Inventiva had 123 total employees, including 120 full-time and 3 part-time employees. The number of employees increased by 10 or 8.85% compared to the previous year.
Employees
123
Change (1Y)
10
Growth (1Y)
8.85%
Revenue / Employee
€156,707
Profits / Employee
€847,041
Market Cap
224.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 151,292 |
Ipsen S.A. | 5,325 |
Eurofins Scientific SE | 61,798 |
ABIVAX Société Anonyme | 61 |
MedinCell S.A. | 134 |
Eurobio Scientific Société anonyme | 300 |
Nanobiotix S.A. | 102 |
Cegedim SA | 6,582 |
Inventiva News
- 18 hours ago - Combined General Meeting of December 11, 2024 - Availability of the preparatory documents - GlobeNewsWire
- 3 days ago - Alight to Enhance the Employee Experience with Launch of Alight Worklife® on Microsoft Teams - Business Wire
- 5 days ago - Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session - GlobeNewsWire
- 21 days ago - Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH - GlobeNewsWire
- 4 weeks ago - Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024 - GlobeNewsWire
- 5 weeks ago - Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants - GlobeNewsWire
- 5 weeks ago - Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday? - Benzinga
- 5 weeks ago - Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday? - Benzinga